Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-2
|
pubmed:dateCreated |
1997-3-20
|
pubmed:abstractText |
Recombinant mouse perlecan domain 1(173 residues) was produced in transfected embryonic kidney cells and purified from the culture medium on DEAE-cellulose. It was shown to be modified by glycosaminoglycans and could be partially separated into two protein pools which were either substituted with heparan sulfate (fragment IA) or, to a smaller extent (20%), with chondroitin/dermatan sulfate or a mixture of both glycosaminoglycans (fragment IB). The average molecular mass of the glycosaminoglycans was about 8-10 kDa and, thus, smaller than in tissue-derived perlecans. Sequence and carbohydrate analyses localized the heparan sulfate attachment site to three Ser residues within SGD consensus sequences. Furthermore, the N-terminal part of fragment IA contained six Thr/Ser residues substituted by branched galactosamine-containing oligosaccharides and an N-substituted Asn residue. Fragment I was also shown to contain unique immunological epitopes which are not dependent on glycosaminoglycans and are shared by tissue-derived perlecan. Circular dichroism demonstrated a distinct alpha helix (20%) and beta structure (60%) in fragment IA, consistent with predictions of a novel SEA protein module located in the C-terminal part of domain I.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Chondroitin Sulfates,
http://linkedlifedata.com/resource/pubmed/chemical/Glycosaminoglycans,
http://linkedlifedata.com/resource/pubmed/chemical/Heparan Sulfate Proteoglycans,
http://linkedlifedata.com/resource/pubmed/chemical/Heparitin Sulfate,
http://linkedlifedata.com/resource/pubmed/chemical/Oligosaccharides,
http://linkedlifedata.com/resource/pubmed/chemical/Proteoglycans,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/perlecan
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0014-2956
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
243
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
115-21
|
pubmed:dateRevised |
2007-7-23
|
pubmed:meshHeading |
pubmed-meshheading:9030729-Amino Acid Sequence,
pubmed-meshheading:9030729-Animals,
pubmed-meshheading:9030729-Chondroitin Sulfates,
pubmed-meshheading:9030729-Circular Dichroism,
pubmed-meshheading:9030729-Epitope Mapping,
pubmed-meshheading:9030729-Glycosaminoglycans,
pubmed-meshheading:9030729-Heparan Sulfate Proteoglycans,
pubmed-meshheading:9030729-Heparitin Sulfate,
pubmed-meshheading:9030729-Mice,
pubmed-meshheading:9030729-Molecular Sequence Data,
pubmed-meshheading:9030729-Oligosaccharides,
pubmed-meshheading:9030729-Protein Conformation,
pubmed-meshheading:9030729-Proteoglycans,
pubmed-meshheading:9030729-Recombinant Proteins
|
pubmed:year |
1997
|
pubmed:articleTitle |
Characterization of recombinant perlecan domain I and its substitution by glycosaminoglycans and oligosaccharides.
|
pubmed:affiliation |
Max-Planck-Institut für Biochemie, Martinsried, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|